Applications of L-Methionine Sulfoximine in Industrial Manufacturing

L-Methionine Sulfoximine serves as a specialized intermediate and bioactive agent in selected industrial sectors where metabolic regulation, targeted toxicity, and enzyme inhibition are critical. As a direct manufacturer, we supply this compound with the analytical traceability and batch consistency required for advanced downstream processing. Here, we outline verified application tracks and integration data from large-scale users.

1. Agrochemical Active Ingredient Synthesis (Herbicide Research)

In the research and pilot manufacturing of novel herbicides, L-Methionine Sulfoximine is widely deployed as a glutamine synthetase inhibitor for structure–activity relationship investigations. Its use supports the development of analogs for selective weed management by modulating ammonia metabolism within target plant tissues. Our end-users incorporate it both in in vivo and in vitro assay systems, as well as in regulated greenhouse screening.

Industry compliance standards

• OECD Principles of Good Laboratory Practice (GLP)
• European Plant Protection Organization (EPPO) guidelines for efficacy evaluation
• Directive 2009/128/EC on the sustainable use of pesticides
• ISO 17025 accredited analytical test requirements

Typical usage ratio

• 0.03%–0.5% w/w in test formulation, adjusted based on targeted weed type and bioassay intensity

Downstream process integration

• Direct addition to herbicide screening solutions during actives comparison phase
• Use in metabolic pathway inhibition modules of laboratory or pilot plant synthesis

Final product types

• Experimental herbicide compound libraries and reference standards
• Lead structure candidates for commercial pesticide development programs

2. Animal Feed Toxicology Reference (Mycotoxin Research)

L-Methionine Sulfoximine provides a key biochemical control for veterinary research on mycotoxin-induced neurotoxicity in livestock feeds. Feed additive manufacturers and contract research organizations employ it to verify glutamine synthetase pathway intervention during in vitro assays, enabling safety evaluation of grain amendments under controlled conditions.

Industry compliance standards

• OECD Test Guideline 474: Mammalian Erythrocyte Micronucleus Test
• US FDA Good Laboratory Practice (GLP) regulations 21 CFR Part 58
• Directive 2010/63/EU for animal protection in scientific research
• ISO/IEC 17025:2017 for analytical laboratory competence

Typical usage ratio

• 0.01%–0.1% by substrate weight in animal feed simulation assays, with exact dosing set according to species and protocol design

Downstream process integration

• Incorporation at the pre-mixing stage of experimental feed batch preparation
• Addition to culture media in cell-based neurotoxicity screens

Final product types

• Reference control feeds for use in regulatory toxicology trials
• Validated negative and positive control materials for mycotoxin detection kit calibration

3. Neuropharmacological Research Intermediate

In neuroscience and preclinical pharmacology labs, L-Methionine Sulfoximine is established as an inhibitor of central and peripheral glutamine synthetase, serving as a chemical tool to induce and study hyperammonemia and seizure models in mammals. Firms manufacturing research-use-only compounds utilize it under stringent purity control and record chain-of-custody, providing input for academic trial lots and reference standard preparation.

Industry compliance standards

• USP General Chapter <1043> Ancillary Materials for Cell, Gene, and Tissue-Engineered Products
• IACUC Guidelines (AAALAC International Accreditation)
• EMA Guideline for the Investigation of Bioequivalence (CPMP/EWP/QWP/1401/98 Rev 1/Corr)
• ISO 9001:2015 certified production quality management

Typical usage ratio

• 0.05–2 mg/kg administered via oral or intraperitoneal route in rodents, titrated by protocol and species

Downstream process integration

• Dissolution into sterile saline or appropriate vehicle during preclinical formulation batch set-up
• Weighed and aliquoted into experimental administration kits

Final product types

• Standardized neurotoxic challenge kits for seizure evaluation studies
• High-purity research reference substances for academic and contract research organizations

4. Enzyme Screening and Metabolic Pathway Assay Kits

Diagnostics and biochemical supplier companies incorporate L-Methionine Sulfoximine into enzyme activity and metabolic disturbance assay kits, specifically targeting glutamine synthetase for mechanistic enzyme inhibition tests. This application supports downstream users involved in metabolic disorder research and enzymatic pathway validation, demanding reproducible batch quality and traceability.

Industry compliance standards

• ISO 13485:2016 for medical devices and diagnostics quality
• Clinical and Laboratory Standards Institute (CLSI) EP17: Protocols for Limit of Detection
• EU In Vitro Diagnostic Regulation (IVDR) (EU) 2017/746
• US Pharmacopeia USP <1043> for ancillary research reagents

Typical usage ratio

• 0.001–0.05 mmol/L in reaction wells or test buffers, specified by manufacturer kit design and intended detection range

Downstream process integration

• Premixing into lyophilized reagent sachets during kit assembly
• Inclusion in enzyme inhibition calibration standard mixtures

Final product types

• Ready-to-use metabolic activity test kits for academic, clinical research, and contract assay service providers
• Reference standards for glutamine synthetase inhibition screening